The warnings, dated December 10, were issued to Prime Peptides, Summit Research Peptides, Swisschems and Xcel Research, all of which were found to be selling unapproved GLP-1 treatments that, despite being labelled as for research purposes, were marketed for human use
Patel, R
Taking periodic breaks from BPC-157 allows the cardiovascular system to return to its baseline state, theoretically preventing accumulating effects that might emerge from uninterrupted use
So, what are you supposed to do when your weight loss journey is less about burning fat than it is about burning time
Chen AL, Lum KM, Lara-Gonzalez P, Ogasawara D, Cognetta AB, To A, Parsons WH, Simon GM, Desai A, Petrascheck M, et al